CDKN2B and bile duct cancer: The methylation profile of the CDKN2B promoter, a cell cycle inhibitor gene, was reduced in cells overexpressing miR‐29b that inhibits bile duct cancer progression by releasing DNMT3B‐mediated inhibition of CDKN2B expression.11